Dexcom Inc
XETRA:DC4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dexcom Inc
XETRA:DC4
|
US |
|
Yankuang Energy Group Co Ltd
SSE:600188
|
CN |
|
Sampo Oyj
F:SMP2
|
FI |
|
F
|
Federal Realty Investment Trust
F:WX2
|
US |
|
C
|
Cellectis SA
SWB:ZVA
|
FR |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
F:AILA
|
FR |
|
Ascencio SCA
F:ZYY
|
BE |
|
X
|
Xinjiang Goldwind Science & Technology Co Ltd
XBER:CXGH
|
CN |
|
JTL Industries Ltd
NSE:JTLIND
|
IN |
|
K
|
Kontoor Brands Inc
XETRA:3KO
|
US |
|
U
|
Unisys Corp
SIX:UIS
|
US |
|
J
|
Johnson & Johnson
XMUN:JNJ
|
US |
|
I
|
Imax Corp
XBER:IMA
|
CA |
|
Fuji Electric Co Ltd
F:FJE
|
JP |
Wall St Price Targets
DC4 Price Targets Summary
Dexcom Inc
According to Wall Street analysts, the average 1-year price target for DC4 is 73.3 EUR with a low forecast of 57.33 EUR and a high forecast of 99.63 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DC4's stock price target?
Price Target
73.3
EUR
According to Wall Street analysts, the average 1-year price target for DC4 is 73.3 EUR with a low forecast of 57.33 EUR and a high forecast of 99.63 EUR.
What is the Revenue forecast for Dexcom Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 5 years is 12%.
What is the Operating Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Operating Income over the next 5 years is 19%.
What is the Net Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Net Income over the next 5 years is 19%.
